Seqster

Healthcare provider sitting and talking to a patient
SEQSTER partners with Antidote Technologies for clinical trial enrollment
By Jessica Hagen | 04:07 pm | July 08, 2024
Antidote will use SEQSTER's operating system to improve clinical trial time lines and enhance patient engagement for pharma and life sciences companies.
Stethoscope, money and a calculator.
Current Health closes $43M Series B for company growth, Medchart raises $17M for product innovation and more digital health fundings
By Mallory Hackett | 03:21 pm | April 22, 2021
Also: Seqster completes Series A round and Oath Care lands $2M ahead of its launch later this year.